.Merck defeats revenues desires, rears sales expectation on strong demand for top drugs like Keytruda CNBCMerck & Co. (MRK United States) Trumps Income Projections as Keytruda Sales Increase BloombergMerck Inventory: Pharma Titan Posts Sturdy Outcomes, Yet Expectation Tumbles Short Real estate investor's Organization DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck beats income as well as purchases assumptions amidst Keytruda strong point, yet offers blended full-year expectation MarketWatch.